LinkOPH

Corneal collagen cross-linking improved visual acuity and prevented the progression of keratoconus for up to 7 years, according to a long-term study investigating the procedure, with no serious complications and no eyes requiring re-treatment.“All eyes were stable 7 years following cross-linking, and between 1 and 5 years, there were continued improvements in corneal shape with K-max reduced and coma improved. Importantly, there were no sight-threatening complications out to 7 to 8 years,” David P.S. O’Brart, MD, FRCS, FRCOphth, the corresponding author, told Ocular Surgery News.

Read more →

The challenge in the glaucoma surgery arena is the continued search for the ultimate glaucoma surgery technique that provides long-term IOP reduction, leading to the elimination of topical glaucoma eye drops, preservation of the ocular surface, along w…

Read more →

El glaucoma puede resultar un problema difícil de controlar en un subgrupo de pacientes, incluso para los especialistas en glaucoma con mayor experiencia. El abanico de tratamientos incluye fármacos, la trabeculoplastía, la cirugía de glaucoma de microincisión y la cirugía de glaucoma tradicional.Mientras que muchos utilizan las medicaciones para glaucoma como tratamiento inicial, otros eligen la trabeculoplastía láser selectiva para el control inicial de la PIO. Se puede controlar la PIO de la mayoría de los pacientes con glaucoma con una o más medicaciones de uso tópico, pero existe un (Read more...)

O glaucoma pode ser um problema de difícil administração em um subconjunto de pacientes, mesmo para os especialistas mais experientes em glaucoma. O espectro de tratamento inclui medicamentos, trabeculoplastia, cirurgia de glaucoma de microincisão e cirurgia de glaucoma tradicional.Embora muitos utilizem medicamentos de glaucoma como sua modalidade inicial de tratamento, outros utilizam a trabeculoplastia seletiva a laser para o controle inicial da PIO. A PIO da maioria dos pacientes de glaucoma pode ser controlada com um ou mais medicamentos tópicos, mas existe um subconjunto de pacientes dos quais a PIO (Read more...)

Both retinal pigment epithelium height and central subfield thickness were reduced in patients with persistent retinal fluid whose treatment was switched to aflibercept from another intravitreal anti-VEGF, according to a study. Visual acuity, however, …

Read more →